CWA Asset Management Group LLC Invests $106,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CWA Asset Management Group LLC acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 3rd quarter, Holdings Channel.com reports. The institutional investor acquired 11,809 shares of the pharmacy operator’s stock, valued at approximately $106,000.

A number of other hedge funds also recently added to or reduced their stakes in WBA. Iron Horse Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares in the last quarter. Blue Trust Inc. increased its holdings in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 1,081 shares during the period. Continuum Advisory LLC raised its stake in Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares in the last quarter. Sentry Investment Management LLC purchased a new stake in Walgreens Boots Alliance during the third quarter worth $30,000. Finally, Eastern Bank bought a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $33,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Up 0.2 %

Shares of Walgreens Boots Alliance stock opened at $9.03 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.22 and a fifty-two week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The company has a market cap of $7.81 billion, a P/E ratio of -0.90, a price-to-earnings-growth ratio of 1.18 and a beta of 0.69. The firm has a 50-day simple moving average of $9.18 and a two-hundred day simple moving average of $12.01.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.67 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 11.07%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is presently -9.99%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on WBA. Evercore ISI boosted their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday, October 7th. TD Cowen reduced their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Finally, Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.